阳光诺和(688621.SH)与北京大学医学部共建联合实验室
Sun-NovoSun-Novo(SH:688621) 智通财经网·2025-12-16 09:18

Core Viewpoint - The company, 阳光诺和, has announced a collaboration with Peking University Health Science Center to establish the "Peking University Medicine - 阳光诺和 Innovation Drug Joint Laboratory" aimed at enhancing independent innovation capabilities and national core competitiveness [1] Group 1: Collaboration Details - The partnership will focus on cutting-edge fields such as cell therapy and gene therapy [1] - The primary goal is to develop clinical candidate drugs, leveraging the strengths of both parties [1] - This initiative is part of the company's strategy to promote high-quality development in the field of innovative drug research and development [1]